(1)
UTILIZATION OF DIAGNOSTIC EFFICACY OF Α-METHYLACYL COA RACEMASE (AMACR) AND P63 IN DIFFERENTIAL DIAGNOSIS OF PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA. JBI 2024, 12 (1), 103-114.